These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32292078)

  • 1. Outcome of patients receiving a continuous flow left ventricular assist device - a retrospective single center study.
    Kiss J; Stark C; Nykänen A; Lemström K
    Scand Cardiovasc J; 2020 Aug; 54(4):212-219. PubMed ID: 32292078
    [No Abstract]   [Full Text] [Related]  

  • 2. A Novel Extracorporeal Continuous-Flow Ventricular Assist System for Patients With Advanced Heart Failure　- Initial Clinical Experience.
    Seguchi O; Fujita T; Kitahata N; Iwasaki K; Kuroda K; Nakajima S; Watanabe T; Yanase M; Fukushima S; Tsukiya T; Katagiri N; Mizuno T; Takewa Y; Hamasaki T; Onda K; Hayashi T; Yamamoto H; Tatsumi E; Kobayashi J; Fukushima N
    Circ J; 2020 Jun; 84(7):1090-1096. PubMed ID: 32461539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Survival of Patients With Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation: The Registry to Evaluate the HeartWare Left Ventricular Assist System.
    Zimpfer D; Fiane AE; Larbalestier R; Tsui S; Jansz P; Simon A; Schueler S; Strueber M; Schmitto JD
    Circ Heart Fail; 2020 Mar; 13(3):e006252. PubMed ID: 32164438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single center outcomes after temporary mechanical circulatory assist device prior to Heartmate 3 implantation - a retrospective cohort study.
    Iversen IJ; Gustafsson F; Rossing K; Møller-Sørensen PH; Olsen PS; Møller CH
    Scand Cardiovasc J; 2024 Dec; 58(1):2353066. PubMed ID: 38962929
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Better With Time: An Economic Assessment of Long-Term Mechanical Circulatory Support in a Population Surviving at Least 1 Year with a Left Ventricular Assist Device.
    Chung JJ; Stetson R; Gordon J; Chen CW; Gaffey AC; Rame JE; Acker M; Atluri P
    Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):738-746. PubMed ID: 30308249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HeartMate II Left Ventricular Assist Device Pump Exchange: A Single-Institution Experience.
    Shaikh AF; Joseph SM; Lima B; Hall SA; Malyala R; Rafael AE; Gonzalez-Stawinski GV; Chamogeorgakis T
    Thorac Cardiovasc Surg; 2017 Aug; 65(5):410-414. PubMed ID: 27903010
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of venopulmonary arterial extracorporeal life support as temporary right ventricular support after left ventricular assist implantation.
    Shehab S; Rao S; Macdonald P; Newton PJ; Spratt P; Jansz P; Hayward CS
    J Thorac Cardiovasc Surg; 2018 Dec; 156(6):2143-2152. PubMed ID: 30025607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
    Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pump replacement on outcome in advanced heart failure patients with left ventricular assist system.
    Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
    Artif Organs; 2013 Jul; 37(7):606-14. PubMed ID: 23692322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy.
    Marasco SF; Lo C; Murphy D; Summerhayes R; Quayle M; Zimmet A; Bailey M
    Artif Organs; 2016 Jan; 40(1):100-6. PubMed ID: 25980985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal Analysis in Outcomes of Long-Term Mechanical Circulatory Support: Retrospective Study.
    Ondrusek M; Artemiou P; Bezak B; Gasparovic I; By TM; Durdik S; Lesny P; Goncalvesova E; Hulman M
    Thorac Cardiovasc Surg; 2024 Oct; 72(7):521-529. PubMed ID: 38641334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk Score.
    Birati EY; Hanff TC; Maldonado D; Grandin EW; Kennel PJ; Mazurek JA; Vorovich E; Seigerman M; Howard JLL; Acker MA; Naka Y; Wald J; Goldberg LR; Jessup M; Atluri P; Margulies KB; Schulze PC; Rame JE
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.